|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Restricted cash | ||||||||||||||
| Investments in marketable securities | ||||||||||||||
| Accounts receivable | ||||||||||||||
| Aircraft support parts | ||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||
| Deferred offering costs | ||||||||||||||
| Total current assets | ||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||
| Intangible assets, net | ||||||||||||||
| Goodwill | ||||||||||||||
| Other noncurrent assets | ||||||||||||||
| Total assets | ||||||||||||||
| LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ DEFICIT | ||||||||||||||
| Liabilities | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | ||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||
| Operating lease right-of-use liabilities (current) | ||||||||||||||
| Current portion of long-term debt, net of debt issuance costs | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Long-term accrued expenses and other noncurrent liabilities | ||||||||||||||
| Operating right-of-use noncurrent liabilities | ||||||||||||||
| Long-term debt, net of debt issuance costs | ||||||||||||||
| Total liabilities | ||||||||||||||
| Series A Preferred Stock, $0.0001 par value; 315,789.473684 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||
| Series A Preferred Stock | ||||||||||||||
| Redeemable Legacy Bridger Series C Preferred Shares | ||||||||||||||
| Total series A Preferred Stock, $0.0001 par value; 315,789.473684 shares authorized, issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||
| STOCKHOLDERS’ DEFICIT | ||||||||||||||
| Common Stock, $0.0001 par value; 1,000,000,000 shares authorized; 58,699,275 shares issued and outstanding at June 30, 2026; 55,894,663 shares issued and outstanding at December 31, 2025 | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||
| Total stockholders’ deficit | ||||||||||||||
| Total liabilities, mezzanine equity and stockholders’ deficit | ||||||||||||||
Loading...